Muscle relaxants for pain management in rheumatoid arthritis.

  title={Muscle relaxants for pain management in rheumatoid arthritis.},
  author={Bethan Richards and Samuel L. Whittle and Rachelle Buchbinder},
  journal={The Cochrane database of systematic reviews},
BACKGROUND Pain management is a high priority for patients with rheumatoid arthritis (RA). Muscle relaxants include drugs that reduce muscle spasm (for example benzodiazepines such as diazepam (Valium), alprazolam (Xanax), lorazepam (Ativan) and non-benzodiazepines such as metaxalone (Skelaxin) or a combination of paracetamol and orphenadrine (Muscol)) and drugs that prevent increased muscle tone (baclofen and dantrolene). Despite a paucity of evidence supporting their use, antispasmodic and… 

Figures from this paper

Balneotherapy (or spa therapy) for rheumatoid arthritis.

This review includes two new studies and a total of nine studies involving 579 participants, which evaluated the effects of balneotherapy in patients with RA in terms of pain, improvement, disability, tender joints, swollen joints and adverse events.

The Association Between Constipation or Stool Consistency and Pain Severity in Patients With Chronic Pain

Constipation displayed a significant and positive association with the pain severity of the total patients and patients with low back and/or lower limb pain, whole body and Simultaneous multiple linear regression analyses revealed that a predictor of thepain severity was the CCS.

Manual Therapy (Postisometric Relaxation and Joint Mobilization) in Knee Pain and Function Experienced by Patients with Rheumatoid Arthritis: A Randomized Clinical Pilot Study

It is suggested that manual therapy (postisometric relaxation and joint mobilization) may have clinical benefits for treating knee pain and function in rheumatoid patients.

Exercise therapies for preventing or treating aromatase inhibitor-induced musculoskeletal symptoms in early breast cancer.

The evidence suggested that exercise therapies result in little to no difference in overall change in stiffness scores and overall survival in women with stage I to III hormone receptor-positive breast cancer, while managing AIMSS was found that the evidence for the effect of exercise therapies on Overall change in worst pain scores was very uncertain.

Systemic therapies for preventing or treating aromatase inhibitor-induced musculoskeletal symptoms in early breast cancer.

The evidence suggests little to no effect on HRQoL and BCS-QOL from baseline to the end of intervention and two studies, investigating vitamin D and omega-3 fatty acids, showed a treatment effect with 95% CIs that did not include an MCID for pain, but the evidence is very uncertain for outcomes assessing incidence of AIMSS.

Increased risk of mental health disorders in patients with RA during the COVID-19 pandemic: a possible surge and solutions

There is a significant association between the adverse impact on the mental health of RA patients and the COVID-19 pandemic, and more research is needed to highlight individual risk factors.

Framing the numerical findings of Cochrane plain language summaries: two randomized controlled trials

Numerical presentation and framing direction of results appear to have no significant impact on understanding of messages in CSR PLSs.



Centrally acting skeletal muscle relaxants and associated drugs.

  • H. J. Waldman
  • Psychology, Biology
    Journal of pain and symptom management
  • 1994

Analgesic effect of alprazolam in patients with chronic, organic pain of malignant origin.

The results of this study suggest that the use of benzodiazepines for patients with this refractory pain syndrome should be evaluated further.


  • E. Tarpley
  • Medicine, Psychology
    Journal of chronic diseases
  • 1965

Clinical and Pharmacological Review of the Efficacy of Orphenadrine and Its Combination with Paracetamol in Painful Conditions

From the available animal data it is concluded that the antinociceptive effect of orphenadrine has been clearly demonstrated but data have also clearly indicated that it has muscle relaxant properties.

Pharmacologic management of cancer pain.

The use of adjuvant analgesics and the use of sequential opioid trials may improve the outcome of therapy for patients who fail to promptly attain a favorable balance between analgesia and side effects during an opioid trial.

Zopiclone as night medication in rheumatoid arthritis.

Treatment with zopiclone may be of value for subjective sleep complaints in selected patients with RA, but it is doubtful whether hypnotics improve daytime symptoms in this patient group.

Night medication in rheumatoid arthritis: II. Combined therapy with indomethacin and diazepam.

It is concluded that the combination of indomethacin and diazepam should now be considered the treatment of choice for maximum control of night pain and morning stiffness in rheumatoid arthritis.

Night medication in rheumatoid arthritis. III. the use of sulindac.

Indomethacin plus diazepam was the most effective of the three regimens, although the differences did not reach conventional statistical significance and it is suggested that in further studies with sulindac a larger dose and a longer duration of treatment should be used.

Night Sedation and Arthritic Pain

This pilot study highlights the problems of benzodiazepine (BDP) usage in patients attending a rheumatology clinic and recommends that if BDP is to be prescribed it should be only in selected cases for a short time.

Pain and disability in osteoarthritis: A review of biobehavioral mechanisms

It is concluded that pain and disability are associated with degeneration of cartilage and bone, with muscle weakness and limitations in joint motion, and with anxiety, coping style, attentional focus on symptoms, and possibly depression.